Gefimipsa
Gefimipsa Products are primarily used for
Pancreatic cancer, Small cell lung cancer, Liver cancer
About Gefimipsa Products
Uses of Gefimipsa Products
Gefitinib is used in the treatment of pancreatic cancer, small cell lung cancer, liver cancer, kidney cancer, thyroid cancer, blood cancer (chronic myeloid leukaemia), gastrointestinal stromal tumour, cancer of colon and rectum, non-small cell lung cancer, soft tissue sarcoma, chronic idiopathic myelofibrosis and breast cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer.
Gefimipsa Products side effects
Common
Side Effects of Gefimipsa are Diarrhea, Nausea, Stomatitis (Inflammation of the mouth), Vomiting, Weakness, Decreased appetite, Fever, Hair loss, Conjunctivitis, Eyelid inflammation, Hemorrhage, Interstitial lung disease, Dryness in mouth, Angioedema (swelling of deeper layers of skin), Urticaria.
How Gefimipsa Products work
Gefitinib is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Patient Concerns about Gefimipsa Products
Frequently asked questions about Gefimipsa Products
Frequently asked questions about Gefitinib
Q. What is Gefimipsa 250mg Capsule used for?
Gefimipsa 250mg Capsule is a prescription medicine used to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that has specific changes in the EGFR gene. It is typically used in people whose cancer has spread and who haven’t received chemotherapy yet.
Q. Who can take Gefimipsa 250mg Capsule?
Gefimipsa 250mg Capsule is recommended for adults with advanced NSCLC that tests positive for certain EGFR mutations. Your doctor will perform a special test before starting Gefimipsa 250mg Capsule treatment to confirm if this medicine is suitable for you.
Q. What are the serious side effects of Gefimipsa 250mg Capsule?
Gefimipsa 250mg Capsule may rarely cause serious side effects, including lung inflammation (interstitial lung disease), liver damage, severe diarrhea, or eye problems. Seek medical help immediately if you experience breathing difficulty, eye pain, yellowing of the skin or eyes, or dark urine.
Q. What precautions should I follow while on Gefimipsa 250mg Capsule treatment?
While taking Gefimipsa 250mg Capsule, you should get regular liver function tests and chest scans, avoid prolonged sun exposure due to skin sensitivity, and report any vision changes or breathing difficulties right away.
Q. How long will I need to take Gefimipsa 250mg Capsule?
You should take Gefimipsa 250mg Capsule for as long as your doctor recommends. Treatment may continue until your cancer progresses or side effects become unmanageable. Regular follow-up tests advised by your doctor will help guide this decision.
Products for Gefimipsa
Gefimipsa 250mg Capsule
strip of 30 capsules
MRP
₹1490
Not Available
Substitute brands for Gefimipsa
Emfib
Emcure Pharmaceuticals Ltd
1 Product
Iressa
AstraZeneca
1 Product
Chemoressa
Biochem Pharmaceutical Industries
1 Product
1 Product
1 Product